M.E. Allison & CO. Inc. Purchases New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 860 shares of the medical equipment provider’s stock, valued at approximately $449,000.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $82,517,000. Diversify Advisory Services LLC grew its position in shares of Intuitive Surgical by 42.4% in the fourth quarter. Diversify Advisory Services LLC now owns 7,227 shares of the medical equipment provider’s stock valued at $3,957,000 after purchasing an additional 2,151 shares in the last quarter. Diversify Wealth Management LLC boosted its stake in Intuitive Surgical by 101.7% during the fourth quarter. Diversify Wealth Management LLC now owns 8,063 shares of the medical equipment provider’s stock valued at $4,414,000 after buying an additional 4,066 shares during the period. LVW Advisors LLC boosted its stake in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares during the period. Finally, Brady Martz Wealth Solutions LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $554,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ISRG. Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Wells Fargo & Company increased their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $592.64 on Monday. The business’s 50 day moving average is $540.66 and its two-hundred day moving average is $499.19. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $597.68. The stock has a market capitalization of $211.09 billion, a P/E ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This trade represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 over the last 90 days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.